Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Smiles: CC1(C)C=CC2=C(O)C(=CC=C2O1)C(=O)/C=C/C1=CC=CS1
Chrysobactin has siderophore activity
a member of the inhibitor of apoptosis (IAP) gene family
Pomalidomide4PEG1amine
InChi: InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H
Trabectedin - CAS# 114899-77-3 pone Smiles: CC1(C)C=CC2=C(O)C(=CC=C2O1)C(=O)/C=C/C1=CC=CS1Trabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug